March 21, 2016 / 8:18 PM / a year ago

BRIEF-Raptor Pharma says Health Canada accepts NDA for procysbi with priority review status

1 Min Read

March 21 (Reuters) - Raptor Pharmaceutical Corp

* Health canada accepted for review its new drug submission for procysbi delayed-release capsules with priority review status Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below